Literature DB >> 20955778

Immune suppression and immune activation in depression.

Joshua Blume1, Steven D Douglas, Dwight L Evans.   

Abstract

Depression has been characterized as a disorder of both immune suppression and immune activation. Markers of impaired cellular immunity (decreased natural killer cell cytotoxicity) and inflammation (elevated IL-6, TNFα, and CRP) have been associated with depression. These immunological markers have been associated with other medical illnesses, suggesting that immune dysregulation may be a central feature common to both depression and to its frequent medical comorbidities. Yet the significant associations of findings of both immune suppression and immune activation with depression raise questions concerning the relationship between these two classes of immunological observations. Depressed populations are heterogeneous groups, and there may be differences in the immune profiles of populations that are more narrowly defined in terms of symptom profile and/or demographic features. There have been few reports concurrently investigating markers of immune suppression and immune activation in the same depressed individuals. An emerging pre-clinical literature suggests that chronic inflammation may directly contribute to the pathophysiology of immune suppression in the context of illnesses such as cancer and rheumatoid arthritis. This literature provides us with specific immunoregulatory mechanisms mediating these relationships that could also explain differences in immune disturbances between subsets of depressed individuals We propose a research agenda emphasizing the assessment of these immunoregulatory mechanisms in large samples of depressed subjects as a means to define the relationships among immune findings (suppression and/or activation) within the same depressed individuals and to characterize subsets of depressed subjects based on shared immune profiles. Such a program of research, building on and integrating our knowledge of the psychoneuroimmunology of depression, could lead to innovation in the assessment and treatment of depression and its medical comorbidities. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955778      PMCID: PMC3025086          DOI: 10.1016/j.bbi.2010.10.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  120 in total

1.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

2.  Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.

Authors:  Charles L Raison; Andrey S Borisov; Matthias Majer; Daniel F Drake; Giuseppe Pagnoni; Bobbi J Woolwine; Gerald J Vogt; Breanne Massung; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

3.  Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study.

Authors:  Shaoyong Su; Andrew H Miller; Harold Snieder; J Douglas Bremner; James Ritchie; Carisa Maisano; Linda Jones; Nancy V Murrah; Jack Goldberg; Viola Vaccarino
Journal:  Psychosom Med       Date:  2008-12-10       Impact factor: 4.312

4.  Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Authors:  Alexander J Muller; Madhav D Sharma; Phillip R Chandler; James B Duhadaway; Mary E Everhart; Burles A Johnson; David J Kahler; Jeanene Pihkala; Alejandro Peralta Soler; David H Munn; George C Prendergast; Andrew L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

5.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

6.  Translating scientific opportunity into public health impact: a strategic plan for research on mental illness.

Authors:  Thomas R Insel
Journal:  Arch Gen Psychiatry       Date:  2009-02

Review 7.  Treatment-resistant depression: critique of current approaches.

Authors:  Chanaka Wijeratne; Perminder Sachdev
Journal:  Aust N Z J Psychiatry       Date:  2008-09       Impact factor: 5.744

8.  A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling.

Authors:  Gregory E Miller; Edith Chen; Jasmen Sze; Teresa Marin; Jesusa M G Arevalo; Richard Doll; Roy Ma; Steve W Cole
Journal:  Biol Psychiatry       Date:  2008-04-28       Impact factor: 13.382

9.  Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.

Authors:  Viola Vaccarino; Marie-Luise Brennan; Andrew H Miller; J Douglas Bremner; James C Ritchie; Frauke Lindau; Emir Veledar; Shaoyong Su; Nancy V Murrah; Linda Jones; Farhan Jawed; Jun Dai; Jack Goldberg; Stanley L Hazen
Journal:  Biol Psychiatry       Date:  2008-06-02       Impact factor: 13.382

10.  Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Charalambos Kartsios; Efi Yiannaki; Polizo Kazila; Georgia Antoniadi; Vassilios Liakopoulos; Dimitra Markala
Journal:  Blood Purif       Date:  2008-05-08       Impact factor: 2.614

View more
  102 in total

1.  Early maternal separation leads to down-regulation of cytokine gene expression.

Authors:  J J Dimatelis; N S Pillay; A K Mutyaba; V A Russell; W M U Daniels; D J Stein
Journal:  Metab Brain Dis       Date:  2012-04-13       Impact factor: 3.584

2.  Ethnic differences in the links between benefit finding and psychological adjustment in people living with HIV.

Authors:  Erin M Fekete; Michael Chatterton; Matthew D Skinta; Stacey L Williams
Journal:  J Behav Med       Date:  2016-01-19

3.  Stress-induced immune-related diseases and health outcomes of pharmacy students: A pilot study.

Authors:  Areej M Assaf
Journal:  Saudi Pharm J       Date:  2012-03-07       Impact factor: 4.330

4.  The change in the amount of immunoglobulins as a response to stress experienced by soldiers on a peacekeeping mission.

Authors:  Raimonda Kvietkauskaite; Ramute Vaicaitiene; Mykolas Mauricas
Journal:  Int Arch Occup Environ Health       Date:  2013-08-13       Impact factor: 3.015

5.  Nontraditional risk factors as mediators of racial differences in diabetes risk.

Authors:  Joni L Strom Williams; Leonard E Egede
Journal:  J Gen Intern Med       Date:  2014-02       Impact factor: 5.128

6.  Gene expression in major depressive disorder.

Authors:  R Jansen; B W J H Penninx; V Madar; K Xia; Y Milaneschi; J J Hottenga; A R Hammerschlag; A Beekman; N van der Wee; J H Smit; A I Brooks; J Tischfield; D Posthuma; R Schoevers; G van Grootheest; G Willemsen; E J de Geus; D I Boomsma; F A Wright; F Zou; W Sun; P F Sullivan
Journal:  Mol Psychiatry       Date:  2015-05-26       Impact factor: 15.992

7.  Psychosocial health conditions and HIV prevalence and incidence in a cohort of men who have sex with men in Bangkok, Thailand: evidence of a syndemic effect.

Authors:  T E Guadamuz; K McCarthy; W Wimonsate; W Thienkrua; A Varangrat; S Chaikummao; A Sangiamkittikul; R D Stall; F van Griensven
Journal:  AIDS Behav       Date:  2014-11

8.  Depression as sickness behavior? A test of the host defense hypothesis in a high pathogen population.

Authors:  Jonathan Stieglitz; Benjamin C Trumble; Melissa Emery Thompson; Aaron D Blackwell; Hillard Kaplan; Michael Gurven
Journal:  Brain Behav Immun       Date:  2015-06-01       Impact factor: 7.217

9.  Reduced immunity to measles in adults with major depressive disorder.

Authors:  Bart N Ford; Robert H Yolken; Faith B Dickerson; T Kent Teague; Michael R Irwin; Martin P Paulus; Jonathan Savitz
Journal:  Psychol Med       Date:  2018-03-19       Impact factor: 7.723

10.  Evaluation of periodontitis in hospital outpatients with major depressive disorder.

Authors:  A C O Solis; A H Marques; C M Pannuti; R F M Lotufo; F Lotufo-Neto
Journal:  J Periodontal Res       Date:  2013-04-16       Impact factor: 4.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.